SciELO - Scientific Electronic Library Online

 
vol.36 número6Influencia de la variante rs670 del gen APOA1 en la respuesta HDL sérica a una dieta hipocalórica enriquecida con grasas poliinsaturadas frente a una enriquecida con grasas monoinsaturadasAsociación entre el consumo de yerba mate y el perfil lipídico en mujeres con sobrepeso índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Nutrición Hospitalaria

versión On-line ISSN 1699-5198versión impresa ISSN 0212-1611

Resumen

FLORES RODRIGUEZ, Josefina et al. Incidence and characteristics of metabolic syndrome in patients of the National Cancer Institute of Mexico. Nutr. Hosp. [online]. 2019, vol.36, n.6, pp.1296-1299.  Epub 24-Feb-2020. ISSN 1699-5198.  http://dx.doi.org/10.20960/nh.02395.

Objective:

the exact prevalence of obesity in Mexico is not well known and varies between sources, but more than 30% of Mexico’s population are obese. Obesity is associated with several diseases such as metabolic syndrome; the latter, along with cancer, have become public health concerns worldwide, and their association has been widely studied in developed countries. The aim of this study was to identify the overall prevalence of metabolic syndrome and to describe its characteristics among first-time cancer patients at a referral center in Mexico.

Methods:

a prospective, observational, cohort study of first-time patients of the National Cancer Institute of Mexico in the period of September 2016-2017. We identified 1,165 first-time patients, and 316 patients with known or recently diagnosed metabolic syndrome were included.

Results:

median age was 55 years old and most were female (81%). The most frequent tumors were breast, gynecological, and hematological growths. Obesity (class 1-3) and abnormal glucose and/or previous diabetes mellitus diagnosis were mostly observed in patients with skin and soft tissue tumors; dyslipidemia, high triglycerides, and/or low HDL-cholesterol were mostly observed in patients with gastrointestinal tumors.

Conclusion:

the prevalence of metabolic syndrome among first-time cancer patients was 27%. As obesity and cancer are of public concern in Mexico, the implementation of preventive strategies for metabolic syndrome patients, focusing on the first level of care during early stages in order to reduce the risk of cancer, is needed.

Palabras clave : Incidence; Metabolic syndrome; Cancer; Mexico.

        · resumen en Español     · texto en Inglés     · Inglés ( pdf )